chthyosis is a category of around 20 skin disorders characterized by skin dryness and scaling. Because the skin resembles fish scales, the disorder receives its name from the Greek word for fish. The market is expanding as a consequence of reasons such as increased demand for fish as a protein source, the prevalence of aquatic animal diseases, and the expanding aquaculture sector. On the market for fish health treatments are immunizations, antibiotics, parasiticides, and other medicines used to cure various fish illnesses, including those affecting the skin. Fish migration between regions, changes in water temperature and environmental pollution are all leading to an increase in the prevalence of fish skin illnesses around the world. It is anticipated that this breakthrough will increase demand for therapies for fish skin disease. The development of sustainable aquaculture practices is receiving more attention from governments and other organizations, which is leading to increased funding for research and the creation of novel cures and treatments for fish skin problems.
The market for Fish Skin Diseases is anticipated to expand at a 7.1% compound annual growth rate (CAGR) by the end of 2030.
Top Companies in the Fish Skin Disease Industry:
1. Zoetis Inc.
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. It was founded in 1952 and headquartered in New Jersey, U.S. It operates in approximately 45 countries. The Bill and Melinda Gates Foundation awarded a $15.3 million grant to Zoetis in March 2023 to support the company's continued research and development of innovative methods to expand veterinary care and diagnostic services, ultimately enhancing livestock health and productivity in Sub-Saharan Africa.
2. Elanco Animal Health
Elanco Animal Health is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. It was founded in 1954 and headquartered in Indiana, U.S. It operates in more than 90 countries worldwide.
3. MSD Animal Health
MSD Animal Health was founded in 1891 and headquartered in Istanbul, Turkey. It operates in more than 140 countries. The DNA TRACEBACK® Fisheries platform, a new DNA-based analytical tool that helps governments and fishery agencies determine the sustainable yield of wild fish stocks as well as our customers determine the total allowable catch for fishermen in their region, will be made available in May 2022 by MSD Animal Health, a division of Merck & Co., Inc., Rahway, New Jersey, USA.
4. Benchmark Holdings
Benchmark Holdings was founded in 2000 and headquartered in Sheffield, the United Kingdom. It operates in 26 countries. In July 2021, the Norwegian Medicines Agency (NoMA) approved Benchmark Holdings' parasiticide BMK08 (imidacloprid), to be known as Ectosan Vet, for the treatment of sea lice in farmed salmon when used in conjunction with their CleanTreat water treatment technology.
5. Phibro Animal Health Corporation
Phibro Animal Health Corporation was founded in 1946 and headquartered in New Jersey, the US. It operates in over 80 countries. In June 2022, a gene therapy for canines (dogs) with mitral valve disease (MVD) will be developed and commercialized thanks to a partnership between Phibro Animal Health Corporation and Rejuvenate Bio, Inc.
6. Intervet Inc.
Intervet Inc. was founded in 1996 and headquartered in United States. It operates in more than 50 countries.
7. Merck Animal Health
Merck Animal Health was founded in 1996 and headquartered in. It operates in New Jersey, United States. The European Commission approved INNOVAX®-ILT-IBD, a dual-construct HVT vaccine that offers long-term protection against infectious laryngotracheitis (ILT), infectious bursal disease (IBD), and Marek's disease (MD), according to a June 2023 announcement from Merck Animal Health, a division of Merck & Co., Inc., Rahway, New Jersey, USA. All European Union nations where INNOVAX-ILT-IBD is authorized will update their national registrations following the centralized approval process.
8. Novartis AG
Novartis AG was founded in 1996 and headquartered in Basel, Switzerland. It operates in about 140 countries. In June 2022, Novartis will reaffirm its commitment to the elimination of malaria and other neglected tropical illnesses by spending USD 250 million over a five-year period on new drug development.
9. Pharmaq AS
Pharmaq AS was founded in 2004 and headquartered in Oslo, Norway. It operates in all the largest salmonid producing countries,
*Definition: A series of uncommon skin diseases known as ichthyosis result in dry, scaly skin. It normally comes with birth, however it can also develop later in life. Most of the time, there is no cure, although there are therapies to ease the symptoms.
